NCT05768672Completed
The Sense of Small and Inhibition in Obesity
Investigating the Relationship Between the Sense of Smell and Cognitive Inhibition in Obesity: a Behavioural Experiment.
Source: ClinicalTrials.gov · Last updated 27 Aug 2025
Brief summary (registry, in English)
The aim of this research is to verify whether inhibitory control ability is different between a group of individuals with obesity and a group of individuals with normal weight in the presence of olfactory stimuli, different for valence, edibility (food versus no-food), and caloric density (high-calorie vs low-calorie content) of foods associated with odours.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 25 (actual)
- First submitted
- 22 Feb 2023
- Start date
- Jan 2023
- Primary completion date
- Jun 2024
- Lead sponsor
- Istituto Auxologico Italiano
- Diseases
- Obesity
- NCT number
- NCT05768672
What you commit to
- Study type: Observational
- Participants enrolled: 25
- From Jan 2023 to the primary completion date, Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent neurological, neurodevelopmental (e.g., autism), motor, somatosensory and/or psychiatric disorders.
Who the study is looking for
- Right-handed
- diagnosis of obesity (i.e., the level of body mass index (BMI) higher or equal to 30).
Age in the registry: 20 years to 55 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Istituto Auxologico Italiano - Ospedale San Giuseppe Coordinator of this site? Confirm its status | Piancavallo | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.